Patents/Assignees

RNAIMMUNE, Inc.

3 patents in portfolio

US12280104utility2025
Composition and Methods for MRNA Vaccines Against Novel Omicron Coronavirus Infections
0 cites
US12280105utility2025
Compositions and Methods of Mrna Vaccines Against Novel Coronavirus Infection
0 cites
US12029786utility2024
Composition and Method of Mrna Vaccines Against Novel Coronavirus Infection
0 cites